Supplemental material
Journal of Drug Assessment
Volume 8, 2019 - Issue 1
Open access
2,666
Views
4
CrossRef citations to date
0
Altmetric
Allergy & Immunology
Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
Kimihiro OkuboDepartment of Otorhinolaryngology, Nippon Medical School, Tokyo, Japan; Correspondence[email protected]
, Takamasa SuzukiTeikoku Seiyaku Co., Ltd, Tokyo, Japan
, Ayaka TanakaTeikoku Seiyaku Co., Ltd, Tokyo, Japan
& Hiroshi AokiTeikoku Seiyaku Co., Ltd, Tokyo, Japan
Pages 104-114
|
Received 19 Mar 2019, Accepted 28 Apr 2019, Published online: 05 Jun 2019
Related Research Data
Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history.
Source:
BMJ
Expectancy in Double-Blind Placebo-Controlled Trials: An Example from Alcohol Dependence
Source:
S. Karger AG
Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
Source:
Public Library of Science (PLoS)
Update on rupatadine in the management of allergic disorders
Source:
Wiley-Blackwell
Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
Source:
Taylor & Francis
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
Recent Trends in Management of Allergic Rhinitis
Source:
Jaypee Brothers Medical Publishing
Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects
Source:
Springer Nature
Clinical Practice Guideline
Source:
SAGE Publications
Sleep and allergic disease: A summary of the literature and future directions for research
Source:
Elsevier BV
The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies
Source:
Springer Nature
Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
Source:
Wiley-Blackwell
Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
Source:
Taylor & Francis
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
An Unexplored Area
Source:
HAL CCSD
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
Expression and localization of platelet-activating factor receptor in human nasal mucosa
Source:
Elsevier BV
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: A 52-week open-label clinical trial
Source:
Taylor & Francis
Ethical Principles for Medical Research Involving Human Subjects
Source:
American Medical Association (AMA)
Role of histamine and platelet-activating factor in allergic rhinitis
Source:
Springer Nature
ARIA: 2008 Update
Source:
Wiley
Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires
Source:
Informa UK Limited
[(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine Derivatives as Dual Antagonists of PAF and Histamine
Source:
American Chemical Society (ACS)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.